Skip to content
ppharmaranks
Menu
Class IIIOngoing

Focalin XR (dexmethylphenidate HCl) 5 mg recall

FDA recall D-0608-2026 · initiated Jun 1, 2026

By the pharmaranks editorial teamReviewed against the FDA (openFDA) sourcesUpdated Jun 24, 2026How we research

Sandoz Inc recalled Focalin XR (dexmethylphenidate HCl) 5 mg in Jun 2026 — an FDA Class III recall (D-0608-2026) because Labeling: Incorrect or Missing Lot and/or Exp Date.

Unlikely to cause harm but violates FDA labeling or manufacturing regulations.

Why it was recalled

Labeling: Incorrect or Missing Lot and/or Exp Date

Labelling, packaging or a product mix-up

The wrong information — or the wrong medicine — ended up in the pack. A mix-up is a manufacturing failure that can still be dangerous to swallow.

This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.

Is your product affected? Check the lot number

A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.

Lot VA0099422; Exp. Date June 30, 2028

Quantity recalled: 7,803 bottles

Details

Product
Focalin XR (dexmethylphenidate HCl) 5 mg, 30 extended-release capsules per bottle, Rx only, Manufactured by Societal CDMO Gainesville, LLC, Gainesville, GA 30504. NDC: 66758-235-31
Recalling company
Sandoz Inc
Classification
Class III
Status
Ongoing
Type
Voluntary: Firm initiated
Distribution
U.S. Nationwide
Initiated
Jun 1, 2026
FDA report date
Jun 24, 2026

This recall is linked to a product we cover: Focalin XR

What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Frequently asked

Was Focalin XR (dexmethylphenidate HCl) 5 mg recalled?
Sandoz Inc recalled Focalin XR (dexmethylphenidate HCl) 5 mg in Jun 2026 — an FDA Class III recall (D-0608-2026) because Labeling: Incorrect or Missing Lot and/or Exp Date. Unlikely to cause harm but violates FDA labeling or manufacturing regulations.
Why was Focalin XR (dexmethylphenidate HCl) 5 mg recalled?
Per the FDA enforcement record, the reason for recall D-0608-2026 was: Labeling: Incorrect or Missing Lot and/or Exp Date
Is a recalled Focalin XR (dexmethylphenidate HCl) 5 mg dangerous to take?
An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. Unlikely to cause harm but violates FDA labeling or manufacturing regulations. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
Which lots of Focalin XR (dexmethylphenidate HCl) 5 mg are affected?
Distributed: U.S. Nationwide. The recall covers these lots — Lot VA0099422; Exp. Date June 30, 2028. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0608-2026.

Source: openFDA Drug Enforcement record D-0608-2026

← All drug recalls